Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 7, 2006; 12(37): 6041-6045
Published online Oct 7, 2006. doi: 10.3748/wjg.v12.i37.6041
Published online Oct 7, 2006. doi: 10.3748/wjg.v12.i37.6041
Table 1 Correlation of DAB2 protein expression with clinicopathological parameters of ESCC patients
| Parameters | Total cases | DAB2 | |
| n | Positive n (%) | Negative n (%) | |
| ESCC | 50 | 16 (32) | 34 (68) |
| Age | |||
| ≤ 40 yr | 14 | 4 (28) | 10 (72) |
| ≥ 40 yr | 36 | 12 (33) | 24 (67) |
| Gender | |||
| Male | 30 | 11 (37) | 19 (63) |
| Female | 20 | 5 (25) | 15 (75) |
| Tumor Stage | |||
| T2 | 3 | 1 | 2 |
| T3 | 36 | 11 (31) | 25 (69) |
| T4 | 11 | 4 (36) | 7 (64) |
| Hp Grading | |||
| WDSCC | 8 | 2 | 6 |
| MDSCC | 37 | 11 (30) | 26 (70) |
| PDSCC | 5 | 3 (60) | 2 (40) |
| Nodal stage | |||
| Node -ve | 23 | 8 (35) | 15 (65) |
| Node +ve | 27 | 8 (30) | 19 (70) |
| Normal | 10 | 10 | |
| Hyperplasia | 30 | 25 (83) | 5 |
| Dysplasia | 15 | 5 | 10 (67) |
- Citation: Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006; 12(37): 6041-6045
- URL: https://www.wjgnet.com/1007-9327/full/v12/i37/6041.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i37.6041